Patent · US Active

Compositions and methods for treating cancer

US8518965B2 · kind B2 · utility

1Cited by
2References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 13, 2010
Grant dateAug 27, 2013
Priority date
Expiry dateJul 22, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention embraces bis-acridine and bis-quinoline intercalators having a bis(4-aminophenyl)ether tether, and diglycolate salts thereof, for selectively decreasing colon cancer and glial cell proliferation and preventing or treating colon cancers and gliomas.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.